{"cursor":"13742","size":15,"audio":[],"currentlang":"en","article":"{{Drugbox\n| Verifiedfields = changed verifiedrevid = 470627281 image =\n\n\n| type = mab mab_type = mab source = u target = IL-12 and IL-23\n\n\n| tradename = Stelara Drugs.com = MedlinePlus = a611013 licence_EU = Stelara\n| licence_US = Ustekinumab pregnancy_AU = \n| pregnancy_US =  pregnancy_category = contraindicated\n| legal_AU =  legal_CA =\n|  legal_UK = POM legal_US =\n| Rx-only legal_status = routes_of_administration = subcutaneous injection\n\n\n| bioavailability = protein_bound = metabolism = elimination_half-life =\n| excretion =\n\n\n| ChemSpiderID_Ref = ChemSpiderID = NA CAS_number_Ref = CAS_number = 815610-63-\n| 0 ATC_prefix = L04 ATC_suffix = AC05 PubChem = DrugBank_Ref = DrugBank =\n| UNII_Ref = UNII = FU77B4U5Z0 KEGG_Ref = KEGG = D09214 ChEMBL_Ref = ChEMBL\n| = 1201835\n\n\n| C=6482 | H=10004 | N=1712 | O=2016 | S=46 molecular_weight = 145.64 kDa\n}} 'Ustekinumab'  (INN, experimental name 'CNTO 1275', proprietary\ncommercial name 'Stelara', European Medicines Agency, 20 November 2008,\nhttp://www.emea.europa.eu/pdfs/human/opinion/Stelara_58227008en.pdf\nCentocor) is a human monoclonal antibody. It is directed against interleukin 12\nand interleukin 23, naturally occurring proteins that regulate the immune system\nand immune-mediated inflammatory disorders.\n\nIn two Phase III trials for moderate to severe psoriasis, the longest >76 weeks,\nustekinumab was safe and effective.\n\nA third Phase III trial, ACCEPT, compared the efficacy and safety of ustekinumab\nwith etanercept in the treatment of moderate to severe plaque psoriasis. This trial found a significantly higher clinical response\nwith ustekinumab over the 12-week study period compared to high-dose\netanercept. It also demonstrated the clinical benefit of\nustekinumab among patients who failed to respond to etanercept.\n\nUstekinumab is approved in Canada, Europe and the United States to treat\nmoderate to severe plaque psoriasis. [http://news.idsk.com/viewer/story.php-\n?CLIENT=INFOMAILER&NEWSID=prn121520081223240607 Medarex to Receive Milestone\nPayment for Approval of STELARA(TM) (Ustekinumab) for the Treatment of Moderate\nto Severe Plaque Psoriasis]\n\n, the drug is being investigated for the treatment of psoriatic\narthritis. It has also been tested in Phase II studies for\nmultiple sclerosis and sarcoidosis, the latter versus golimumab\n(Simponi).\n","linknr":605,"url":"ustekinumab","recorded":1376420417,"links":["/w/index.php?title=Ustekinumab&action=edit","/w/index.php?title=Ustekinumab&action=edit","//bits.wikimedia.org/favicon/wikipedia.ico","/w/opensearch_desc.php","//en.wikipedia.org/w/api.php?action=rsd","//creativecommons.org/licenses/by-sa/3.0/","/w/index.php?title=Special:RecentChanges&feed=atom","http://en.wikipedia.org/wiki/Ustekinumab","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.gadget.DRN-wizard%2CReferenceTooltips%2Ccharinsert%2Cteahouse%7Cext.rtlcite%2Cwikihiero%7Cext.uls.nojs%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmw.PopUpMediaTransform%7Cskins.vector&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.visualEditor.viewPageTarget.noscript&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=startup&only=scripts&skin=vector&*","//bits.wikimedia.org/geoiplookup","//meta.wikimedia.org","#mw-navigation","#p-search","/wiki/Nomenclature_of_monoclonal_antibodies","/wiki/Monoclonal_antibody#Applications","/wiki/File:Engineered_monoclonal_antibodies.svg","/wiki/Monoclonal_antibody#Production","/wiki/Human","/wiki/Antigen","/wiki/Interleukin_12","/wiki/Interleukin_23","/wiki/Trade_name","/wiki/American_Society_of_Health-System_Pharmacists","/wiki/Drugs.com","http://www.drugs.com/monograph/ustekinumab.html","/wiki/MedlinePlus","http://www.nlm.nih.gov/medlineplus/druginfo/meds/a611013.html","/wiki/Regulation_of_therapeutic_goods","/wiki/European_Medicines_Agency","http://www.ema.europa.eu/ema/index.jsp?curl=/pages/medicines/landing/epar_search.jsp&murl=menus/medicines/medicines.jsp&searchkwByEnter=true&status=Authorised&keyword=Stelara&searchType=Name&jsenabled=true","/wiki/U.S._Food_and_Drug_Administration","http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Ustekinumab&SearchType=BasicSearch","/wiki/Pregnancy_category","/wiki/Regulation_of_therapeutic_goods","/wiki/Prescription_drug","/wiki/United_Kingdom","/wiki/Prescription_drug","/wiki/United_States","/wiki/Route_of_administration","/wiki/Subcutaneous_injection","/wiki/CAS_registry_number","http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?term=815610-63-0&rn=1","//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png","/wiki/Anatomical_Therapeutic_Chemical_Classification_System","/wiki/ATC_code_L04","http://www.whocc.no/atc_ddd_index/?code=L04AC05","/wiki/Unique_Ingredient_Identifier","http://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=FU77B4U5Z0","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","/wiki/KEGG","http://www.kegg.jp/entry/D09214","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","/wiki/ChEMBL","https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL1201835","//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png","/wiki/Chemical_formula","/wiki/Carbon","/wiki/Hydrogen","/wiki/Nitrogen","/wiki/Oxygen","/wiki/Sulfur","/wiki/Molecular_mass","/wiki/Atomic_mass_unit","//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/14px-X_mark.svg.png","/wiki/Wikipedia:WikiProject_Chemicals/Chembox_validation","//en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=470627281&page2=Ustekinumab","#cite_note-1","/wiki/International_Nonproprietary_Name","#cite_note-2","/wiki/Centocor","/wiki/Monoclonal_antibody","/wiki/Interleukin_12","/wiki/Interleukin_23","#cite_note-pmid17761156-3","/wiki/Clinical_trial#Phase_III","/wiki/Psoriasis","#cite_note-PHOENIX1-4","#cite_note-PHOENIX2-5","/wiki/Etanercept","#cite_note-Griffiths-6","#cite_note-Griffiths-6","#cite_note-Griffiths-6","#cite_note-7","//en.wikipedia.org/w/index.php?title=Ustekinumab&action=edit","/wiki/Psoriatic_arthritis","#cite_note-8","#cite_note-9","/wiki/Multiple_sclerosis","#cite_note-10","/wiki/Sarcoidosis","/wiki/Golimumab","#cite_note-11","#Development","#Delivery","#Mechanism_of_action","#Efficacy","#Adverse_effects","#Tolerability","#References","#External_links","/w/index.php?title=Ustekinumab&action=edit&section=1","/w/index.php?title=Ustekinumab&veaction=edit&section=1","//en.wikipedia.org/w/index.php?title=Ustekinumab&action=edit","/wiki/Biologic_License_Application","/wiki/Janssen-Cilag","#cite_note-12","#cite_note-centocor.com-13","#cite_note-centocor.com-13","/wiki/Etanercept","/wiki/Baylor_University","#cite_note-14","#cite_note-Kornbluth-15","/w/index.php?title=Ustekinumab&action=edit&section=2","/w/index.php?title=Ustekinumab&veaction=edit&section=2","/wiki/Subcutaneous_injection","/w/index.php?title=Ustekinumab&action=edit&section=3","/w/index.php?title=Ustekinumab&veaction=edit&section=3","/wiki/Inflammation","/wiki/Cytokines","/wiki/Interleukin","/wiki/Interleukin_12","/wiki/Interleukin_23","/wiki/T_cell","/w/index.php?title=Ustekinumab&action=edit&section=4","/w/index.php?title=Ustekinumab&veaction=edit&section=4","#cite_note-ustekinu-16","#cite_note-ustekinu-16","#cite_note-ustekMS-17","/w/index.php?title=Ustekinumab&action=edit&section=5","/w/index.php?title=Ustekinumab&veaction=edit&section=5","/wiki/Tuberculosis","/wiki/Cancer","/wiki/Cyclosporine","/wiki/Posterior_reversible_encephalopathy_syndrome","/wiki/Allergic_reaction","/wiki/Upper_respiratory_infection","/wiki/Headache","/wiki/Tiredness","#cite_note-18","/w/index.php?title=Ustekinumab&action=edit&section=6","/w/index.php?title=Ustekinumab&veaction=edit&section=6","#cite_note-ustekinu-16","/w/index.php?title=Ustekinumab&action=edit&section=7","/w/index.php?title=Ustekinumab&veaction=edit&section=7","#cite_ref-1","http://www.landesbioscience.com/journals/17/article/8593/","/wiki/Digital_object_identifier","http://dx.doi.org/10.4161%2Fmabs.1.3.8593","/wiki/PubMed_Central","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2726595","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/20069753","#cite_ref-2","http://www.emea.europa.eu/pdfs/human/opinion/Stelara_58227008en.pdf","#cite_ref-pmid17761156_3-0","http://linkinghub.elsevier.com/retrieve/pii/S0008-8749(07)00149-9","/wiki/Digital_object_identifier","http://dx.doi.org/10.1016%2Fj.cellimm.2007.06.006","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/17761156","#cite_ref-PHOENIX1_4-0","/wiki/Digital_object_identifier","http://dx.doi.org/10.1016%2FS0140-6736%2808%2960725-4","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/18486739","#cite_ref-PHOENIX2_5-0","/wiki/Mark_G._Lebwohl","/wiki/Digital_object_identifier","http://dx.doi.org/10.1016%2FS0140-6736%2808%2960726-6","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/18486740","#cite_ref-Griffiths_6-0","#cite_ref-Griffiths_6-1","#cite_ref-Griffiths_6-2","/wiki/The_New_England_Journal_of_Medicine","/wiki/Digital_object_identifier","http://dx.doi.org/10.1056%2FNEJMoa0810652","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/20071701","#cite_ref-7","http://news.idsk.com/viewer/story.php?CLIENT=INFOMAILER&NEWSID=prn121520081223240607","#cite_ref-8","/wiki/ClinicalTrials.gov","http://www.clinicaltrials.gov/show/NCT00267956","#cite_ref-9","/wiki/ClinicalTrials.gov","http://www.clinicaltrials.gov/show/NCT01009086","#cite_ref-10","/wiki/ClinicalTrials.gov","http://www.clinicaltrials.gov/show/NCT00207727","#cite_ref-11","/wiki/ClinicalTrials.gov","http://www.clinicaltrials.gov/show/NCT00955279","#cite_ref-12","http://www.empr.com/stelara-approved-for-moderate-to-severe-psoriasis/article/149760/","#cite_ref-centocor.com_13-0","#cite_ref-centocor.com_13-1","http://www.centocor.com/centocor/i/press_releases/FDA_ISSUES_COMPLETE_RESPONSE_LETTER_TO_CENTOCOR_FOR_USTEKINUMAB_BIOLOGIC_LICENSE_APPLICATION_","#cite_ref-14","http://ap.google.com/article/ALeqM5h_tdxEcXc1GVJ0JaD3-pP7hKEFRQD93947K00","/wiki/Wikipedia:Link_rot","#cite_ref-Kornbluth_15-0","http://www.gastroendonews.com/ViewArticle.aspx?d=In+the+News&d_id=187&i=November+2011&i_id=789&a_id=19714","#cite_ref-ustekinu_16-0","#cite_ref-ustekinu_16-1","#cite_ref-ustekinu_16-2","http://adisonline.com/biodrugs/pages/articleviewer.aspx?year=2009&issue=23010&article=00006&type=abstract","/wiki/Digital_object_identifier","http://dx.doi.org/10.2165%2F00063030-200923010-00006","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/19344192","#cite_ref-ustekMS_17-0","http://linkinghub.elsevier.com/retrieve/pii/S1474-4422(08)70173-X","/wiki/Digital_object_identifier","http://dx.doi.org/10.1016%2FS1474-4422%2808%2970173-X","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/18703004","#cite_ref-18","http://www.stelarainfo.com/safety","/w/index.php?title=Ustekinumab&action=edit&section=8","/w/index.php?title=Ustekinumab&veaction=edit&section=8","http://www.centocororthobiotech.com/cobi/index.html","/wiki/National_Institutes_of_Health","/wiki/ClinicalTrials.gov","http://www.clinicaltrials.gov/show/NCT00207727","/wiki/ClinicalTrials.gov","http://www.clinicaltrials.gov/show/NCT00320216","/wiki/ClinicalTrials.gov","http://www.clinicaltrials.gov/show/NCT00267969","/wiki/ClinicalTrials.gov","http://www.clinicaltrials.gov/show/NCT00307437","/wiki/ClinicalTrials.gov","http://www.clinicaltrials.gov/show/NCT00267956","http://www.docguide.com/news/content.nsf/news/852571020057CCF685257129005140C5","/wiki/Template:Immunosuppressants","/wiki/Template_talk:Immunosuppressants","//en.wikipedia.org/w/index.php?title=Template:Immunosuppressants&action=edit","/wiki/Immunomodulator","/wiki/Immunosuppressive_drug","/wiki/Immunosuppressant","/wiki/ATC_code_L04","/wiki/Antimetabolite","/wiki/Purine_synthesis_inhibitor","/wiki/Azathioprine","/wiki/Mycophenolic_acid","/wiki/Pyrimidine_synthesis_inhibitor","/wiki/Leflunomide","/wiki/Teriflunomide","/wiki/Antifolate","/wiki/Methotrexate","/wiki/Macrolide","/wiki/Interleukin_2","/wiki/FKBP","/wiki/Cyclophilin","/wiki/Calcineurin","/wiki/Tacrolimus","/wiki/Ciclosporin","/wiki/Pimecrolimus","/wiki/Abetimus","/wiki/Gusperimus","/wiki/Thalidomide","/wiki/Lenalidomide","/wiki/Interleukin_1_receptor_antagonist","/wiki/Anakinra","/wiki/Mammalian_target_of_rapamycin","/wiki/Sirolimus","/wiki/Everolimus","/wiki/Ridaforolimus","/wiki/Temsirolimus","/wiki/Umirolimus","/wiki/Zotarolimus","/wiki/Antibody","/wiki/Monoclonal_antibodies","/wiki/Complement_component_5","/wiki/Eculizumab","/wiki/TNF_inhibitor","/wiki/Adalimumab","/wiki/Afelimomab","/wiki/Certolizumab_pegol","/wiki/Golimumab","/wiki/Infliximab","/wiki/Nerelimomab","/wiki/Interleukin_5","/wiki/Mepolizumab","/wiki/Immunoglobulin_E","/wiki/Omalizumab","/wiki/Interferon","/wiki/Faralimomab","/wiki/Interleukin_6","/wiki/Elsilimomab","/wiki/Interleukin_12","/wiki/Interleukin_23","/wiki/Lebrikizumab","/wiki/CD3_(immunology)","/wiki/Muromonab-CD3","/wiki/Otelixizumab","/wiki/Teplizumab","/wiki/Visilizumab","/wiki/CD4","/wiki/Clenoliximab","/wiki/Keliximab","/wiki/Zanolimumab","/wiki/CD11a","/wiki/Efalizumab","/wiki/CD18","/wiki/Erlizumab","/wiki/CD20","/wiki/Afutuzumab","/wiki/Rituximab","/wiki/Ocrelizumab","/wiki/Pascolizumab","/wiki/CD23","/wiki/Gomiliximab","/wiki/Lumiliximab","/wiki/CD40_(protein)","/wiki/Teneliximab","/wiki/Toralizumab","/wiki/L-selectin","/wiki/Aselizumab","/wiki/CD80","/wiki/Galiximab","/wiki/Basigin","/wiki/Gavilimomab","/wiki/CD154","/wiki/Ruplizumab","/wiki/Belimumab","/wiki/CTLA-4","/wiki/Ipilimumab","/wiki/Tremelimumab","/wiki/Chloramphenicol_acetyltransferase","/wiki/Bertilimumab","/wiki/Lerdelimumab","/wiki/Metelimumab","/wiki/Integrin","/wiki/Natalizumab","/wiki/Interleukin-6_receptor","/wiki/Tocilizumab","/wiki/Lymphocyte_function-associated_antigen_1","/wiki/Odulimomab","/wiki/IL-2_receptor","/wiki/Basiliximab","/wiki/Daclizumab","/wiki/Inolimomab","/wiki/T_cell","/wiki/Zolimomab_aritox","/wiki/Atorolimumab","/wiki/Cedelizumab","/wiki/Fontolizumab","/wiki/Maslimomab","/wiki/Morolimumab","/wiki/Pexelizumab","/wiki/Reslizumab","/wiki/Rovelizumab","/wiki/Siplizumab","/wiki/Talizumab","/wiki/Telimomab_aritox","/wiki/Vapaliximab","/wiki/Vepalimomab","/wiki/Polyclonal_antibodies","/wiki/Anti-thymocyte_globulin","/wiki/Anti-lymphocyte_globulin","/wiki/Fusion_protein","/wiki/CTLA-4","/wiki/Abatacept","/wiki/Belatacept","/wiki/TNF_inhibitor","/wiki/Etanercept","/wiki/Pegsunercept","/wiki/Aflibercept","/wiki/Alefacept","/wiki/Rilonacept","/wiki/Template:Medicine_navs","/wiki/Lymphocyte","/wiki/Template:Lymphocytes","/wiki/Template:Lymphocytic_immune_system","/wiki/Template:Autoantigens","/wiki/Template:Autoantibodies","/wiki/Template:Complement_system","/wiki/Template:Immunoglobulin_superfamily_immune_receptors","/wiki/Template:Lymphoid_and_complement_immunodeficiency","/wiki/Template:Immunoproliferative_immunoglobulin_disorders","/wiki/Template:Hypersensitivity_and_autoimmune_diseases","/wiki/Template:Lymphoid_malignancy","/wiki/Template:Immunologic_techniques_and_tests","/wiki/Template:Immunostimulants","/wiki/Template:Immunosuppressants","/wiki/Template:Monoclonals_for_immune_system","/wiki/Template_talk:Monoclonals_for_immune_system","//en.wikipedia.org/w/index.php?title=Template:Monoclonals_for_immune_system&action=edit","/wiki/Monoclonal_antibodies","/wiki/Immune_system","/wiki/Immune_system","/wiki/Immunosuppression","/wiki/Adalimumab","/wiki/Anifrolumab","/wiki/Atorolimumab","/wiki/Belimumab","/wiki/Brodalumab","/wiki/Carlumab","/wiki/Dupilumab","/wiki/Eldelumab","/wiki/Fresolimumab","/wiki/Golimumab","/wiki/Lerdelimumab","/wiki/Lirilumab","/wiki/Mavrilimumab","/wiki/Metelimumab","/wiki/Morolimumab","/wiki/Namilumab","/wiki/Oxelumab","/wiki/Placulumab","/wiki/Sarilumab","/wiki/Sifalimumab","/wiki/Tabalumab","/wiki/Ipilimumab","/wiki/Tremelimumab","/wiki/Nivolumab","/wiki/Urelumab","/wiki/Bertilimumab","/wiki/Zanolimumab","/wiki/Afelimomab","/wiki/Elsilimomab","/wiki/Faralimomab","/wiki/Gavilimomab","/wiki/Inolimomab","/wiki/Maslimomab","/wiki/Nerelimomab","/wiki/Odulimomab","/wiki/Telimomab_aritox","/wiki/Vepalimomab","/wiki/Zolimomab_aritox","/wiki/Chimeric_antibody","/wiki/Basiliximab","/wiki/Clenoliximab","/wiki/Galiximab","/wiki/Gomiliximab","/wiki/Infliximab","/wiki/Keliximab","/wiki/Lumiliximab","/wiki/Priliximab","/wiki/Teneliximab","/wiki/Vapaliximab","/wiki/Humanized_antibody","/wiki/Aselizumab","/wiki/Apolizumab","/wiki/Benralizumab","/wiki/Cedelizumab","/wiki/Certolizumab_pegol","/wiki/Daclizumab","/wiki/Eculizumab","/wiki/Efalizumab","/wiki/Epratuzumab","/wiki/Erlizumab","/wiki/Etrolizumab","/wiki/Fontolizumab","/wiki/Itolizumab","/wiki/Lambrolizumab","/wiki/Lampalizumab","/wiki/Ligelizumab","/wiki/Mepolizumab","/wiki/Mogamulizumab","/wiki/Natalizumab","/wiki/Ocrelizumab","/wiki/Omalizumab","/wiki/Ozoralizumab","/wiki/Pascolizumab","/wiki/Pateclizumab","/wiki/Pexelizumab","/wiki/Pidilizumab","/wiki/PRO_140","/wiki/Reslizumab","/wiki/Rontalizumab","/wiki/Rovelizumab","/wiki/Ruplizumab","/wiki/Quilizumab","/wiki/Samalizumab","/wiki/Siplizumab","/wiki/Talizumab","/wiki/Teplizumab","/wiki/Tocilizumab","/wiki/Toralizumab","/wiki/Tregalizumab","/wiki/Vatelizumab","/wiki/Vedolizumab","/wiki/Visilizumab","/wiki/TGN1412","/wiki/Ibalizumab","/wiki/Otelixizumab","/wiki/Interleukin","/wiki/Briakinumab","/wiki/Canakinumab","/wiki/Fezakinumab","/wiki/Guselkumab","/wiki/Secukinumab","/wiki/Sirukumab","/wiki/Tralokinumab","/wiki/Anrukinzumab","/wiki/Clazakizumab","/wiki/Enokizumab","/wiki/Gevokizumab","/wiki/Ixekizumab","/wiki/Lebrikizumab","/wiki/Olokizumab","/wiki/Perakizumab","/wiki/Tildrakizumab","/wiki/Lesion","/wiki/Besilesomab","/wiki/Technetium_(99mTc)_fanolesomab","/wiki/Lemalesomab","/wiki/Technetium_(99mTc)_sulesomab","/wiki/List_of_World_Health_Organization_Essential_Medicines","/wiki/List_of_withdrawn_drugs","/wiki/Clinical_trial","/wiki/Clinical_trial#Phase_III","/wiki/Clinical_trial#Phase_II","/wiki/Template:Medicine_navs","/wiki/Lymphocyte","/wiki/Template:Lymphocytes","/wiki/Template:Lymphocytic_immune_system","/wiki/Template:Autoantigens","/wiki/Template:Autoantibodies","/wiki/Template:Complement_system","/wiki/Template:Immunoglobulin_superfamily_immune_receptors","/wiki/Template:Lymphoid_and_complement_immunodeficiency","/wiki/Template:Immunoproliferative_immunoglobulin_disorders","/wiki/Template:Hypersensitivity_and_autoimmune_diseases","/wiki/Template:Lymphoid_malignancy","/wiki/Template:Immunologic_techniques_and_tests","/wiki/Template:Immunostimulants","/wiki/Template:Immunosuppressants","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","http://en.wikipedia.org/w/index.php?title=Ustekinumab&oldid=545766839","/wiki/Help:Category","/wiki/Category:Centocor","/wiki/Category:Immunosuppressants","/wiki/Category:Monoclonal_antibodies","/wiki/Category:All_articles_with_dead_external_links","/wiki/Category:Articles_with_dead_external_links_from_November_2012","/wiki/Category:Articles_with_changed_CASNo","/wiki/Category:Chemical_compounds_which_do_not_have_a_ChemSpiderID","/wiki/Category:Articles_with_changed_EBI_identifier","/wiki/Category:Drugboxes_which_contain_changes_to_verified_fields","/wiki/Category:Articles_containing_potentially_dated_statements_from_November_2009","/wiki/Category:All_articles_containing_potentially_dated_statements","/wiki/Category:Articles_containing_potentially_dated_statements_from_January_2007","/w/index.php?title=Special:UserLogin&returnto=Ustekinumab&type=signup","/w/index.php?title=Special:UserLogin&returnto=Ustekinumab","/wiki/Ustekinumab","/wiki/Talk:Ustekinumab","#","/wiki/Ustekinumab","/w/index.php?title=Ustekinumab&action=edit","/w/index.php?title=Ustekinumab&veaction=edit","/w/index.php?title=Ustekinumab&action=history","#","/w/index.php","//bits.wikimedia.org/static-1.22wmf12/skins/vector/images/search-ltr.png?303-4","/wiki/Main_Page","/wiki/Main_Page","/wiki/Portal:Contents","/wiki/Portal:Featured_content","/wiki/Portal:Current_events","/wiki/Special:Random","https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&utm_medium=sidebar&utm_campaign=C13_en.wikipedia.org&uselang=en","/wiki/Help:Contents","/wiki/Wikipedia:About","/wiki/Wikipedia:Community_portal","/wiki/Special:RecentChanges","//en.wikipedia.org/wiki/Wikipedia:Contact_us","/wiki/Special:WhatLinksHere/Ustekinumab","/wiki/Special:RecentChangesLinked/Ustekinumab","/wiki/Wikipedia:File_Upload_Wizard","/wiki/Special:SpecialPages","/w/index.php?title=Ustekinumab&oldid=545766839","/w/index.php?title=Ustekinumab&action=info","//www.wikidata.org/wiki/Q420305","/w/index.php?title=Special:Cite&page=Ustekinumab&id=545766839","/w/index.php?title=Special:Book&bookcmd=book_creator&referer=Ustekinumab","/w/index.php?title=Special:Book&bookcmd=render_article&arttitle=Ustekinumab&oldid=545766839&writer=rl","/w/index.php?title=Ustekinumab&printable=yes","//de.wikipedia.org/wiki/Ustekinumab","//es.wikipedia.org/wiki/Ustekinumab","//fr.wikipedia.org/wiki/Ustekinumab","//nl.wikipedia.org/wiki/Ustekinumab","//pt.wikipedia.org/wiki/Ustecinumab","//sk.wikipedia.org/wiki/Ustekinumab","#","//www.wikidata.org/wiki/Q420305#sitelinks-wikipedia","//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License","//creativecommons.org/licenses/by-sa/3.0/","//wikimediafoundation.org/wiki/Terms_of_Use","//wikimediafoundation.org/wiki/Privacy_policy","//www.wikimediafoundation.org/","//wikimediafoundation.org/wiki/Privacy_policy","/wiki/Wikipedia:About","/wiki/Wikipedia:General_disclaimer","//en.wikipedia.org/wiki/Wikipedia:Contact_us","//en.m.wikipedia.org/wiki/Ustekinumab","//wikimediafoundation.org/","//bits.wikimedia.org/images/wikimedia-button.png","//www.mediawiki.org/","//bits.wikimedia.org/static-1.22wmf12/skins/common/images/poweredby_mediawiki_88x31.png","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=scripts&skin=vector&*"],"instances":[],"pdf":["http://www.emea.europa.eu/pdfs/human/opinion/Stelara_58227008en.pdf"],"categories":["Centocor","Immunosuppressants","Monoclonal antibodies"],"headings":["Development","Delivery","Mechanism of action","Efficacy","Adverse effects","Tolerability","References","External links"],"image":["//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png","//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/14px-X_mark.svg.png","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","//bits.wikimedia.org/static-1.22wmf12/skins/vector/images/search-ltr.png?303-4","//bits.wikimedia.org/images/wikimedia-button.png","//bits.wikimedia.org/static-1.22wmf12/skins/common/images/poweredby_mediawiki_88x31.png"],"tags":[],"members":[],"related":["Interleukin_12","Interleukin_23","Subcutaneous_injection","Atomic_mass_unit","International_Nonproprietary_Name","Centocor","Monoclonal_antibody","Interleukin_12","Interleukin_23","Psoriasis","Etanercept","Psoriatic_arthritis","Multiple_sclerosis","Sarcoidosis","Golimumab","Biologic_License_Application","Janssen-Cilag","Etanercept","Baylor_University","Subcutaneous_injection","Inflammation","Cytokines","Interleukin","Interleukin_12","Interleukin_23","T_cell","Tuberculosis","Cancer","Cyclosporine","Posterior_reversible_encephalopathy_syndrome","Allergic_reaction","Upper_respiratory_infection","Headache","Tiredness","National_Institutes_of_Health"]}